Inhibition of head and neck tumor cell growth with arachidonic acid metabolism inhibition

Laryngoscope

Volumn 106, Issue 2, 1996, Pages 129-134

  Ondrey, Frank G ^a   Juhn, Steven K ^a   Adams, George L ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5,8,11,14 ICOSATETRAYNOIC ACID; ARACHIDONATE LIPOXYGENASE; ARACHIDONIC ACID; DNA; INDOMETACIN; LEUKOTRIENE; LIPOXYGENASE INHIBITOR; NORDIHYDROGUAIARETIC ACID; PROSTAGLANDIN SYNTHASE; SC 41661; UNCLASSIFIED DRUG;

ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER INHIBITION; CELL COUNT; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG CYTOTOXICITY; DRUG MECHANISM; HEAD AND NECK TUMOR; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; SQUAMOUS CELL CARCINOMA;

ARACHIDONIC ACID; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYCLOOXYGENASE INHIBITORS; HEAD AND NECK NEOPLASMS; HUMANS; INDOMETHACIN; TUMOR CELLS, CULTURED;

EID: 0030040796     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-199602000-00003     Document Type: Article

References (26)

1. Wolf, G.T. and Hong, W.K.: Induction Chemotherapy as Part of a New Treatment Strategy to Preserve the Larynx in Advanced Laryngeal Cancer. In: Head and Neck Cancer (Vol. 3), J.T. Johnson and M.S. Didolker (Eds.). Elsevier, New York, 1993.
2. Panje, W.R.: Regression of Head and Neck Carcinoma With a Prostaglandin-Synthesis Inhibitor. Arch Otolaryngol, 107:658-663, 1981.
3. Braun, D.P., Taylor, G. and Harris, J.E.: Modulation of Immunity in Cancer Patients by Prostaglandin Antagonists. In: Immunity to Cancer II. M.S. Mitchell (Ed.). Alan R. Liss, New York, pp. 439-448, 1989.
4. Smith, W.L., Borgeat, P. and Fitzpatrick, T.: The Eicosanoids: Cyclooxygenase, Lipoxygenase, and Epoxygenase Pathways. In: Biochemistry of Lipids, Lipoproteins, and Membranes. D.E. Vance and J. Vance (Eds.). Elsevier, New York, 1991.
5. Honn, K.V., Cicone, B. and Skoff, A.: Prostacyclin: A Potent Antimetastatic Agent. Science, 212:1270, 1981.
6. Honn, K.V. and Sloane, B.F.: Prostacycline, Thromboxane, and Hematogenous Metastasis. Adv Prostaglandin Thromboxane Leukotriene Res, 12:313, 1983.
7. Karmali, R.A., Horrobin, D.F., Menezes, J., et al.: The Relationship Between Concentrations of Prostaglandin A1, E1, E2a and Rates of Cell Proliferation. Pharmacol Res Commun, 11:69-75, 1979.
8. Pentland, A.P. and Needleman, P.: Modulation of Keratinocyte Proliferation In Vitro by Endogenous Prostaglandin Synthesis. J Clin Invest, 77:246-251, 1986.
9. Bailey, J.M., Bryant, R.W., Low, C.E., et al.: Regulation of T-Lymphocyte Mitogenesis by the Leukocyte Product 15-Hydroxy-Eicosatetraenoic Acid (15-HETE). Cell Immunol, 67:112-120, 1982.
10. Baud, L., Sraer, J., Perez, J., et al.: Leukotriene C4 Binds to Human Glomerular Epithelial Cells and Promotes Their Proliferation In Vitro. J Clin Invest, 76:374-377, 1985.
11. 4. Cancer Res, 49:1138-1142, 1989.
12. Wilson, D.E., Digianfillipo, A., Ondrey, F.G., et al.: Effects of Nordihydroguaiaretic Acid on Cultured Rat and Human Glioma Cell Proliferation. J Neurosurg, 71:551-557, 1989.
13. Rheinwald, J.G. and Beckett, M.A.: Tumorigenic Keratinocyte Lines Requiring Achorage and Fibroblast Support Cultured from Human Squamous Cell Carcinomas. Cancer Res, 41:1657-1663, 1981.
14. Hartzman, R.J., Bach, M.L., Bach, F.H., et al.: Precipitation of Radioactively Labeled Samples: A Semi-Automatic Multiple-Sample Processor. Cell Immunol, 4:182-186, 1972.
15. Reinsmoen, N.L.: Cellular Methods. In: American Society for Histocompatibility and Immunogenetics Laboratory Manual (3rd ed.). D.L. Phelan, et al. (Eds.), 1994.
16. Termijtelen, A. and Bradley, B.A.: Mixed Lymphocyte Reaction and Primed Lymphocyte Typing. In: Histocompatibility Techniques. H.M. Dick and F. Nielsen (Eds.). Elsevier North Holland Biomedical Press, Amsterdam, 1979.
17. Anderson, K.M., Wygodny, J.B., Ondrey, F., et al.: Human PC-3 Cell Line DNA Synthesis is Suppressed by ETYA, an in Vitro Inhibitor of Arachidonic Acid Metabolism. Prostate, 12:3-12, 1988.
18. Kuhn, H., Holzhutter, H.G., Schewe, T., et al.: The Mechanism of Inactivation of Lipoxygenases by Acetylenic Fatty Acids. Eur J Biochem, 139:577-583, 1984.
19. Levinson, S.L. and Hedli, C.C.: Inhibition of 5-Lipoxygenase Activity in Rat Basophilic Leukemia (RBL-1) Cells and Cell-Free Homogenates. Biochemistry and Pharmacology of Mediators. 42:884-887, 1983.
20. Klapan, I., Katic, V., Culo, F., et al.: Prognostic Significance of Plasma Prostaglandin E Concentration in Patients With Head and Neck Cancer. J Cancer Res Clin Oncol, 118:308-313, 1992.
21. 2 and Prostacyclin Concentrations in Squamous Cell Carcinoma of the Head and Neck. J Surg Oncol, 38:33-37, 1988.
22. Pinto, S., Gallo, O., Dilaghi, M., et al.: Prostaglandins in Squamous Cell Carcinoma of the Larynx: Tumor and Peritumor Synthesis. Prostaglandins Leukot Essent Fatty Acids, 39:53-57, 1990.
23. Cenik, Z., Cenik, Z. and Uyar, Y.: Larynx Cancer and Prostaglandins. Am J Otolaryngol, 11:81-84, 1990.
24. Jung TK., Berlinger NT. and Juhn. SK: Prostaglandins in Squamous Cell Carcinoma of the Head and Neck: A Preliminary Study. Laryngoscope. 95:307-312, 1985.
25. 4 and Oral Cancer. Br J Oral Maxillofac Surg, 28:155-159, 1990.
26. Smigel, K.: Aspirin's Next Conquest: Does It Prevent Colon Cancer? J Natl Cancer Inst, 86:3:166-168, 1994.